Skip to main content
Clinical Trials/NCT01319227
NCT01319227
Unknown
N/A

Periprosthetic Bone Remodeling Around Two Different Types of Uncemented Femoral Stems and Two Uncemented Acetabular Components in Total Hip Arthroplasty

Danderyd Hospital1 site in 1 country51 target enrollmentOctober 2009
ConditionsOsteoarthritis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Danderyd Hospital
Enrollment
51
Locations
1
Primary Endpoint
Bone remodelling, i e change in bone mineral density around the stem, as measured with dual energy x-ray absorptiometry (DEXA)
Last Updated
9 years ago

Overview

Brief Summary

This is a randomized clinical trial comparing two different uncemented femoral stems and two different uncemented sockets using Dual-energy x-ray absorptiometry, Radiostereometry and clinical evaluation.

Hypothesis:

  1. A short uncemented stem gives less periprosthetic bone resorption in the proximal femur than a conventional uncemented stem.
  2. An uncemented acetabular component with a backside of three-dimensional Titanium porous construct gives less periprosthetic bone resorption than a backside covered with a conventional porous coating with Titanium-beads and a hydroxy-apatite layer.

Detailed Description

Consecutive patients 40-70 years old who are being planned for Total Hip Arthroplasty (THA) will be eligible for inclusion in the study. Periprosthetic bone remodeling, migration of the components and clinical scores will be recorded prospectively.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
August 2023
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Danderyd Hospital
Responsible Party
Principal Investigator
Principal Investigator

Olof Skoldenberg

Consultant Orthopaedic Surgeon

Danderyd Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 40-70 years old
  • Primary osteoarthritis of the hip
  • Type A or B femur according to Dorr10
  • Femoral anatomy allowing implantation of both femoral stems
  • Willingness and ability to follow study-protocol -

Exclusion Criteria

  • Inflammatory arthritis
  • Abnormal femoral anatomy after hip dysplasia, not suitable for implantation of components
  • Treatment with bisphosphonates, cortisol or cytostatic drugs 6 months prior to surgery
  • Ongoing oestrogen treatment
  • Type C femur according to Dorr
  • Not suited for the study for other reason (surgeons preference)

Outcomes

Primary Outcomes

Bone remodelling, i e change in bone mineral density around the stem, as measured with dual energy x-ray absorptiometry (DEXA)

Time Frame: bone mineral density (BMD) measured postoperatively at 2 years.

Bone remodelling, i e change in bone mineral density behind the acetabular component, as measured with dual energy x-ray absorptiometry (DEXA)

Time Frame: bone mineral density (BMD) measured postoperatively at 2 years

Secondary Outcomes

  • Migration of stem components in six degrees of freedom and maximum total point motion measured with radiostereometric analysis (RSA)(at 2 years)
  • Migration of acetabular components in six degrees of freedom and maximum total point motion of the head center measured with radiostereometric analysis (RSA)(at 6 and 10 years)
  • Bone remodelling, i e change in bone mineral density around the stem and cup, as measured with dual energy x-ray absorptiometry (DEXA)(at 6 and 10 years.)

Study Sites (1)

Loading locations...

Similar Trials